How do I buy prescription medication?

Aqupharm Intravenous Fluid

Aqupharm Intravenous Fluid

  • 4% Dextrose saline » 500ml £5.50
  • 5% Dextrose saline » 500ml £8.50
  • Hartmanns No.11 Solution » 250ml £5.50
  • Hartmanns No.11 Solution » 500ml £7.00
  • Hartmanns No.11 Solution » 1 litre £7.99
  • Normal Saline (0.9%Sodium Chloride) » 500ml £5.99
  • Normal Saline (0.9%Sodium Chloride) » 1000ml £7.99

Selection of 7 products from

£5.50 to £8.50

Description

Sterile solution for injection. used for dehydration and other conditions in all species.


Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

Hartmanns No.11 Solution » 500ml

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Aqupharm 11 (Hartmann’s) Solution for Infusion (UK/IE)

Ringer- Lactat Animalcare solution for infusion (IS, DK, FI, SE)

Aqupharm Ringer Lactate Solution for Infusion (FR, AT, BE, HU, NL, PL)

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each ml contains:

Active substance:

Sodium chloride 6.00 mg Potassium chloride 0.40 mg Calcium chloride 0.204 mg (as dihydrate) Corresponding to calcium chloride dihydrate 0.27 mg Sodium S-lactate 3.20 mg (as sodium lactate (50% w/v)

Sodium 131 mmol/litre Potassium 5 mmol/litre Calcium 2 mmol/litre Bicarbonate (as lactate) 29 mmol/litre Chloride 111 mmol/litre

For the full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Solution for infusion Clear, colourless particle free solution

  1. CLINICAL PARTICULARS

4.1 Target species

Cattle, Horses, Sheep, Goats, Pigs, Dogs, Cats and Rabbits

4.2 Indications for use, specifying the target species

Treatment of dehydration of extracellular predominance. Treatment and prevention of perioperative hypovolaemia and haemorrhagic shock. Treatment of mild metabolic acidosis.

4.3 Contraindications

Do not use in animals with: - congestive heart failure, - hyperkalaemia, - hypercalcaemia, - metabolic alkalosis, - hyperhydration, - severe metabolic or lactic acidosis, - hepatic insufficiency, - Addison's disease. - hypernatraemia

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered. Maintain aseptic precautions. This product does not contain an antimicrobial preservative. It is intended for single use only and any unused contents should be discarded.

The solution should be warmed to approximately to 37° C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. The volume and infusion rate must be adapted to the clinical status of each animal.

Use of this solution requires monitoring of the clinical and physiological status of the animal especially in cases of: - severe renal impairment, - cardiac impairment - sodium retention with oedema, - treatments with corticosteroids and their derivatives.

Monitor serum potassium and serum calcium in treated animals, particularly potassium levels in cases at risk of hyperkalaemia, such as during chronic renal failure.

In animals with hepatic impairment, the product may not produce its alkalising action since lactate metabolism may be altered.

Do not inject intramuscularly.

ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals

None

4.6 Adverse reactions (frequency and seriousness)

The use of the product can cause metabolic alkalosis, in cases of excessive administration or impaired metabolism of lactate.

Not known under normal conditions of use. Where the product is used as a drug carrier, this can lead to other adverse effects.

4.7 Use during pregnancy, lactation or lay

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

Interactions linked to calcium. In case of concomitant blood transfusion, the product should not be administered with the blood in the same infusion set due to the risk of clotting. This veterinary medicinal product contains calcium. Do not add drugs to this solution that may bind (chelate) to calcium.

4.9 Amounts to be administered and administration route

Administer by intravenous infusion.

Management of dehydration including patients with mild metabolic acidosis

The amount of fluid and electrolytes to be administered should be calculated by adding the existing deficits to the ongoing maintenance requirements and any ongoing fluid losses (e.g. from ongoing vomiting, diarrhoea etc) estimated from the history of the animal, clinical examination and laboratory findings.

To calculate the existing fluid deficit, the following equation should be used;

Fluid deficit (mls) = Percentage dehydration x Bodyweight (kg) x 10

(e.g. for a 10 kg dog with 5% dehydration the fluid deficit would be 5 x 10 x 10 = 500ml)

To calculate the ongoing maintenance requirement, the following equation should be used;

Maintenance for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats (mls) = 50ml x Bodyweight (kg) per day

Maintenance of Rabbits (mls) = 75-100ml x Bodyweight (kg) per day

(e.g. for a 10 kg dog, the daily maintenance fluid requirement is 10 x 50 = 500ml)

The administration rate should be adjusted to each animal. The objective is to correct the deficit over 12 – 24 hours.

Prevention of peri-operative hypovolaemia

Administer at a rate of 5 – 10ml/kg/hr during anaesthesia

Treatment of hypovolaemic and haemorrhagic shock

Cattle, Horses, Sheep, Goats, Pigs, Dogs Rabbits; up to 90ml/kg/hr

Cats; up to 60ml/kg/hr

High infusion rates should not be continued for longer than 1 hour.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

In the presence of volume overload signs (e.g. restlessness, moist lung sounds, tachycardia, tachypnoea or coughing), treatment should involve administering diuretics and stopping the infusion.

An excessive infusion of product may cause metabolic alkalosis due to the presence of lactate ions.

4.11 Withdrawal period(s)

Meat and offal: zero days. Milk: zero hours

  1. PHARMACOLOGICAL IMMUNOLOGICAL PROPERTIES

Pharmacotherapeutic group: Solutions affecting the electrolyte balance

ATC vet code: QB05BB01.

5.1 Pharmacodynamic properties

Isotonic crystalloid solutions are for vascular filling and electrolyte replacement. They have an ionic composition very close to the extracellular fluid. Sodium is the major cation of extracellular fluid. It is responsible for maintaining the volume of liquid and extracellular osmolarity. Potassium is mainly an intracellular cation. 99% of calcium is present in the skeleton. Chloride is essentially an extracellular anion. Lactate produces bicarbonate salts (hence its alkalising effect).

5.2 Pharmacokinetic particulars

The solution diffuses into the extracellular space whose volume is increased accordingly. The lactate ion is rapidly metabolised by the liver where it is converted to pyruvate used in the Krebs cycle with production of bicarbonates.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment)

Water for injections

6.2 Incompatibilities

Compatibility with other medications should be checked prior to mixing in order to avoid precipitate formation, turbidity, or a problem with the pH.

Reference should be made to the SPC of the drug being co-administered for incompatibilities information.

This veterinary medicinal product is incompatible with chlortetracycline, amphotericin B, oxytetracycline, methylprednisolone, and sodium lactate or sodium bicarbonate intravenous infusions. Mixtures with additives and other drugs (e.g. oxalate-, phosphate- and carbonate-/hydrogen carbonate-containing ones) may cause incompatibilities.

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale 3 years

After first opening, use immediately and dispose of any unused product.

6.4 Special precautions for storage

This veterinary medicinal does not require any special storage conditions.

6.5 Nature and composition of immediate packaging

Polyvinyl chloride (PVC) bag with polyisoprene/polycarbonate ports, overwrapped with polypropylene

Pack sizes Cardboard box containing 30 bags of 250 ml 20 bags of 500 ml 10 bags of 1000 ml 4 bags of 3000ml 2 bags of 5000ml

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

  1. MARKETING AUTHORISATION HOLDER

Animalcare Limited 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

Vm 10347/4039

  1. DATE OF FIRST AUTHORISATION

22 September 2016

  1. DATE OF REVISION OF THE TEXT

September 2016

Approved: 22/09/2016

Hartmanns No.11 Solution » 1 litre

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Aqupharm 11 (Hartmann’s) Solution for Infusion (UK/IE)

Ringer- Lactat Animalcare solution for infusion (IS, DK, FI, SE)

Aqupharm Ringer Lactate Solution for Infusion (FR, AT, BE, HU, NL, PL)

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each ml contains:

Active substance:

Sodium chloride 6.00 mg Potassium chloride 0.40 mg Calcium chloride 0.204 mg (as dihydrate) Corresponding to calcium chloride dihydrate 0.27 mg Sodium S-lactate 3.20 mg (as sodium lactate (50% w/v)

Sodium 131 mmol/litre Potassium 5 mmol/litre Calcium 2 mmol/litre Bicarbonate (as lactate) 29 mmol/litre Chloride 111 mmol/litre

For the full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Solution for infusion Clear, colourless particle free solution

  1. CLINICAL PARTICULARS

4.1 Target species

Cattle, Horses, Sheep, Goats, Pigs, Dogs, Cats and Rabbits

4.2 Indications for use, specifying the target species

Treatment of dehydration of extracellular predominance. Treatment and prevention of perioperative hypovolaemia and haemorrhagic shock. Treatment of mild metabolic acidosis.

4.3 Contraindications

Do not use in animals with: - congestive heart failure, - hyperkalaemia, - hypercalcaemia, - metabolic alkalosis, - hyperhydration, - severe metabolic or lactic acidosis, - hepatic insufficiency, - Addison's disease. - hypernatraemia

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered. Maintain aseptic precautions. This product does not contain an antimicrobial preservative. It is intended for single use only and any unused contents should be discarded.

The solution should be warmed to approximately to 37° C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. The volume and infusion rate must be adapted to the clinical status of each animal.

Use of this solution requires monitoring of the clinical and physiological status of the animal especially in cases of: - severe renal impairment, - cardiac impairment - sodium retention with oedema, - treatments with corticosteroids and their derivatives.

Monitor serum potassium and serum calcium in treated animals, particularly potassium levels in cases at risk of hyperkalaemia, such as during chronic renal failure.

In animals with hepatic impairment, the product may not produce its alkalising action since lactate metabolism may be altered.

Do not inject intramuscularly.

ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals

None

4.6 Adverse reactions (frequency and seriousness)

The use of the product can cause metabolic alkalosis, in cases of excessive administration or impaired metabolism of lactate.

Not known under normal conditions of use. Where the product is used as a drug carrier, this can lead to other adverse effects.

4.7 Use during pregnancy, lactation or lay

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

Interactions linked to calcium. In case of concomitant blood transfusion, the product should not be administered with the blood in the same infusion set due to the risk of clotting. This veterinary medicinal product contains calcium. Do not add drugs to this solution that may bind (chelate) to calcium.

4.9 Amounts to be administered and administration route

Administer by intravenous infusion.

Management of dehydration including patients with mild metabolic acidosis

The amount of fluid and electrolytes to be administered should be calculated by adding the existing deficits to the ongoing maintenance requirements and any ongoing fluid losses (e.g. from ongoing vomiting, diarrhoea etc) estimated from the history of the animal, clinical examination and laboratory findings.

To calculate the existing fluid deficit, the following equation should be used;

Fluid deficit (mls) = Percentage dehydration x Bodyweight (kg) x 10

(e.g. for a 10 kg dog with 5% dehydration the fluid deficit would be 5 x 10 x 10 = 500ml)

To calculate the ongoing maintenance requirement, the following equation should be used;

Maintenance for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats (mls) = 50ml x Bodyweight (kg) per day

Maintenance of Rabbits (mls) = 75-100ml x Bodyweight (kg) per day

(e.g. for a 10 kg dog, the daily maintenance fluid requirement is 10 x 50 = 500ml)

The administration rate should be adjusted to each animal. The objective is to correct the deficit over 12 – 24 hours.

Prevention of peri-operative hypovolaemia

Administer at a rate of 5 – 10ml/kg/hr during anaesthesia

Treatment of hypovolaemic and haemorrhagic shock

Cattle, Horses, Sheep, Goats, Pigs, Dogs Rabbits; up to 90ml/kg/hr

Cats; up to 60ml/kg/hr

High infusion rates should not be continued for longer than 1 hour.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

In the presence of volume overload signs (e.g. restlessness, moist lung sounds, tachycardia, tachypnoea or coughing), treatment should involve administering diuretics and stopping the infusion.

An excessive infusion of product may cause metabolic alkalosis due to the presence of lactate ions.

4.11 Withdrawal period(s)

Meat and offal: zero days. Milk: zero hours

  1. PHARMACOLOGICAL IMMUNOLOGICAL PROPERTIES

Pharmacotherapeutic group: Solutions affecting the electrolyte balance

ATC vet code: QB05BB01.

5.1 Pharmacodynamic properties

Isotonic crystalloid solutions are for vascular filling and electrolyte replacement. They have an ionic composition very close to the extracellular fluid. Sodium is the major cation of extracellular fluid. It is responsible for maintaining the volume of liquid and extracellular osmolarity. Potassium is mainly an intracellular cation. 99% of calcium is present in the skeleton. Chloride is essentially an extracellular anion. Lactate produces bicarbonate salts (hence its alkalising effect).

5.2 Pharmacokinetic particulars

The solution diffuses into the extracellular space whose volume is increased accordingly. The lactate ion is rapidly metabolised by the liver where it is converted to pyruvate used in the Krebs cycle with production of bicarbonates.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment)

Water for injections

6.2 Incompatibilities

Compatibility with other medications should be checked prior to mixing in order to avoid precipitate formation, turbidity, or a problem with the pH.

Reference should be made to the SPC of the drug being co-administered for incompatibilities information.

This veterinary medicinal product is incompatible with chlortetracycline, amphotericin B, oxytetracycline, methylprednisolone, and sodium lactate or sodium bicarbonate intravenous infusions. Mixtures with additives and other drugs (e.g. oxalate-, phosphate- and carbonate-/hydrogen carbonate-containing ones) may cause incompatibilities.

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale 3 years

After first opening, use immediately and dispose of any unused product.

6.4 Special precautions for storage

This veterinary medicinal does not require any special storage conditions.

6.5 Nature and composition of immediate packaging

Polyvinyl chloride (PVC) bag with polyisoprene/polycarbonate ports, overwrapped with polypropylene

Pack sizes Cardboard box containing 30 bags of 250 ml 20 bags of 500 ml 10 bags of 1000 ml 4 bags of 3000ml 2 bags of 5000ml

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

  1. MARKETING AUTHORISATION HOLDER

Animalcare Limited 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

Vm 10347/4039

  1. DATE OF FIRST AUTHORISATION

22 September 2016

  1. DATE OF REVISION OF THE TEXT

September 2016

Approved: 22/09/2016

Hartmanns No.11 Solution » 250ml

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Aqupharm 11 (Hartmann’s) Solution for Infusion (UK/IE)

Ringer- Lactat Animalcare solution for infusion (IS, DK, FI, SE)

Aqupharm Ringer Lactate Solution for Infusion (FR, AT, BE, HU, NL, PL)

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each ml contains:

Active substance:

Sodium chloride 6.00 mg Potassium chloride 0.40 mg Calcium chloride 0.204 mg (as dihydrate) Corresponding to calcium chloride dihydrate 0.27 mg Sodium S-lactate 3.20 mg (as sodium lactate (50% w/v)

Sodium 131 mmol/litre Potassium 5 mmol/litre Calcium 2 mmol/litre Bicarbonate (as lactate) 29 mmol/litre Chloride 111 mmol/litre

For the full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Solution for infusion Clear, colourless particle free solution

  1. CLINICAL PARTICULARS

4.1 Target species

Cattle, Horses, Sheep, Goats, Pigs, Dogs, Cats and Rabbits

4.2 Indications for use, specifying the target species

Treatment of dehydration of extracellular predominance. Treatment and prevention of perioperative hypovolaemia and haemorrhagic shock. Treatment of mild metabolic acidosis.

4.3 Contraindications

Do not use in animals with: - congestive heart failure, - hyperkalaemia, - hypercalcaemia, - metabolic alkalosis, - hyperhydration, - severe metabolic or lactic acidosis, - hepatic insufficiency, - Addison's disease. - hypernatraemia

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered. Maintain aseptic precautions. This product does not contain an antimicrobial preservative. It is intended for single use only and any unused contents should be discarded.

The solution should be warmed to approximately to 37° C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. The volume and infusion rate must be adapted to the clinical status of each animal.

Use of this solution requires monitoring of the clinical and physiological status of the animal especially in cases of: - severe renal impairment, - cardiac impairment - sodium retention with oedema, - treatments with corticosteroids and their derivatives.

Monitor serum potassium and serum calcium in treated animals, particularly potassium levels in cases at risk of hyperkalaemia, such as during chronic renal failure.

In animals with hepatic impairment, the product may not produce its alkalising action since lactate metabolism may be altered.

Do not inject intramuscularly.

ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals

None

4.6 Adverse reactions (frequency and seriousness)

The use of the product can cause metabolic alkalosis, in cases of excessive administration or impaired metabolism of lactate.

Not known under normal conditions of use. Where the product is used as a drug carrier, this can lead to other adverse effects.

4.7 Use during pregnancy, lactation or lay

The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

Interactions linked to calcium. In case of concomitant blood transfusion, the product should not be administered with the blood in the same infusion set due to the risk of clotting. This veterinary medicinal product contains calcium. Do not add drugs to this solution that may bind (chelate) to calcium.

4.9 Amounts to be administered and administration route

Administer by intravenous infusion.

Management of dehydration including patients with mild metabolic acidosis

The amount of fluid and electrolytes to be administered should be calculated by adding the existing deficits to the ongoing maintenance requirements and any ongoing fluid losses (e.g. from ongoing vomiting, diarrhoea etc) estimated from the history of the animal, clinical examination and laboratory findings.

To calculate the existing fluid deficit, the following equation should be used;

Fluid deficit (mls) = Percentage dehydration x Bodyweight (kg) x 10

(e.g. for a 10 kg dog with 5% dehydration the fluid deficit would be 5 x 10 x 10 = 500ml)

To calculate the ongoing maintenance requirement, the following equation should be used;

Maintenance for Cattle, Horses, Sheep, Goats, Pigs, Dogs and Cats (mls) = 50ml x Bodyweight (kg) per day

Maintenance of Rabbits (mls) = 75-100ml x Bodyweight (kg) per day

(e.g. for a 10 kg dog, the daily maintenance fluid requirement is 10 x 50 = 500ml)

The administration rate should be adjusted to each animal. The objective is to correct the deficit over 12 – 24 hours.

Prevention of peri-operative hypovolaemia

Administer at a rate of 5 – 10ml/kg/hr during anaesthesia

Treatment of hypovolaemic and haemorrhagic shock

Cattle, Horses, Sheep, Goats, Pigs, Dogs Rabbits; up to 90ml/kg/hr

Cats; up to 60ml/kg/hr

High infusion rates should not be continued for longer than 1 hour.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

In the presence of volume overload signs (e.g. restlessness, moist lung sounds, tachycardia, tachypnoea or coughing), treatment should involve administering diuretics and stopping the infusion.

An excessive infusion of product may cause metabolic alkalosis due to the presence of lactate ions.

4.11 Withdrawal period(s)

Meat and offal: zero days. Milk: zero hours

  1. PHARMACOLOGICAL IMMUNOLOGICAL PROPERTIES

Pharmacotherapeutic group: Solutions affecting the electrolyte balance

ATC vet code: QB05BB01.

5.1 Pharmacodynamic properties

Isotonic crystalloid solutions are for vascular filling and electrolyte replacement. They have an ionic composition very close to the extracellular fluid. Sodium is the major cation of extracellular fluid. It is responsible for maintaining the volume of liquid and extracellular osmolarity. Potassium is mainly an intracellular cation. 99% of calcium is present in the skeleton. Chloride is essentially an extracellular anion. Lactate produces bicarbonate salts (hence its alkalising effect).

5.2 Pharmacokinetic particulars

The solution diffuses into the extracellular space whose volume is increased accordingly. The lactate ion is rapidly metabolised by the liver where it is converted to pyruvate used in the Krebs cycle with production of bicarbonates.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment)

Water for injections

6.2 Incompatibilities

Compatibility with other medications should be checked prior to mixing in order to avoid precipitate formation, turbidity, or a problem with the pH.

Reference should be made to the SPC of the drug being co-administered for incompatibilities information.

This veterinary medicinal product is incompatible with chlortetracycline, amphotericin B, oxytetracycline, methylprednisolone, and sodium lactate or sodium bicarbonate intravenous infusions. Mixtures with additives and other drugs (e.g. oxalate-, phosphate- and carbonate-/hydrogen carbonate-containing ones) may cause incompatibilities.

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale 3 years

After first opening, use immediately and dispose of any unused product.

6.4 Special precautions for storage

This veterinary medicinal does not require any special storage conditions.

6.5 Nature and composition of immediate packaging

Polyvinyl chloride (PVC) bag with polyisoprene/polycarbonate ports, overwrapped with polypropylene

Pack sizes Cardboard box containing 30 bags of 250 ml 20 bags of 500 ml 10 bags of 1000 ml 4 bags of 3000ml 2 bags of 5000ml

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

  1. MARKETING AUTHORISATION HOLDER

Animalcare Limited 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

Vm 10347/4039

  1. DATE OF FIRST AUTHORISATION

22 September 2016

  1. DATE OF REVISION OF THE TEXT

September 2016

Approved: 22/09/2016

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews (1)

Q & A

Below are some recent questions we've received regarding Aqupharm Intravenous Fluid, including answers from our team.

18 May 2017 at 11:12am

Expiry date

Crystal Davies

  • VioVet customer since 2017
  • From: Merseyside , United Kingdom

What is the expiry date from when purchased, for opened and un opened

  • Veterinary Advisor

It depends which of the fluids you order but usually the expiry date is at least 2 years from the date of manufacture if unopened. Once opened it should really be used within a month.